Clinical trial
Carperitide in Acute Respiratory Distress Syndrome (ARDS)
NCT00030121 · Suntory Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00030121 |
|---|---|
| Title | Carperitide in Acute Respiratory Distress Syndrome (ARDS) |
| Official title | A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS |
| Lead sponsor | Suntory Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome |
| Intervention type | Drug |
| Interventions | recombinant human atrial natriuretic polypeptide |
| Start date | Dec 1, 1999 |
| First posted | Feb 1, 2002 |
| Last update posted | Feb 20, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: